Rickets Clinical Trial - Hypophosphatemic Rickets in Norway

Status Active, not recruiting

Clinical Trial Summary

The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01057186
Study type	Observational
Source	Haukeland University Hospital
Contact
Status	Active, not recruiting
Phase	N/A
Start date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT02237534` - Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia	Phase 4
Completed	`NCT01252771` - Phosphate Kinetic Modeling 2	Phase 4
Completed	`NCT01187628` - Long-term Study in Chronic Kidney Disease (Extension From Study 14817)	Phase 3
Unknown status	`NCT01245517` - The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient	N/A
Completed	`NCT00506441` - A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia	Phase 3
Recruiting	`NCT04440696` - To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder	Phase 1/Phase 2
Completed	`NCT01976572` - Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects	Phase 1
Completed	`NCT01742585` - A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis	Phase 3
Completed	`NCT01191255` - A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis	Phase 3
Completed	`NCT01003223` - Phosphate Kinetic Modeling	N/A
Completed	`NCT00505037` - A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis	Phase 2
Completed	`NCT00508885` - The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients	Phase 1/Phase 2
Completed	`NCT04551300` - A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients	Phase 2
Completed	`NCT01955876` - Fosrenol Post-marketing Surveillance in Japan	N/A
Completed	`NCT04579315` - Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease	N/A
Completed	`NCT03861247` - Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients	Phase 3
Terminated	`NCT01725113` - Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol	Phase 4
Recruiting	`NCT01238588` - The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan	N/A
Completed	`NCT00542815` - A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia	Phase 3
Completed	`NCT04549597` - Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia	Phase 4